Joerg Ahlgrimm is the CEO of SK pharmteco, a leading global contract development and manufacturing organization (CDMO). Shaped by his early life in East Germany, Joerg developed an agile, ambitious leadership mindset built to thrive in complex, high-stakes environments. His 25+ year career includes executive leadership roles at industry giants, including a 15-year tenure at Baxter and a role as Head of Global Operations at Lonza, where he scaled the manufacturing footprint from 12 to 37 facilities.Demonstrating a unique blend of corporate scale and entrepreneurial drive, Joerg pivoted to become the founding CEO of the Center for Breakthrough Medicines, transforming a conceptual idea into a premier cell and gene therapy startup and a major operation.Now leading SK pharmteco, Joerg has successfully integrated these diverse startup and commercial assets into a unified, multimodal global platform. Recognized for his industry-wide contributions to BioPhorum’s Strategic Advisory Board, Joerg is a progressive leader who rejects superficial metrics. He champions a corporate culture rooted in trust, transparent execution, and an unwavering commitment to the end patient, demonstrating that technical excellence and human empathy are codependent.
